The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
The effect of BiPAP on maximum exercise capacity in patients with COPD Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011
What is the relationship between inspiratory capacity and different measures of exercise capacity in patients with COPD? Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Optimizing baseline constant work rate exercise test duration for COPD bronchodilator studies Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020
Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients? Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Improvements in inspiratory capacity with tiotropium in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002
Peak exercise capacity in patients with COPD. A comparison of three different test protocols Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004
The effectiveness of procaterol on functional exercise capacity in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 182s Year: 2005
Bronchodilation or pulmonary rehabilitation:which test of exercise performance yields the greatest response for patients with stable COPD? An RCT. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
The effect of bronchodilation on symptom time course during exercise in COPD Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010
Inspiratory capacity (IC) and dyspnea during recovery from symptom-limited exercise in COPD patients treated with tiotropium Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Respiratory muscle strength and perception of dyspnea during bronchodilator response test in patients with stable COPD Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
A single dose of tiotropium produces a significant improvement in 6-minute walk distance in severe COPD subjects Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Evaluation of hyperinflation parameters and exercise performance at maximal exercise in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005
Is pulmonary rehabilitation impact different regarding the 6 minute walk test distance in hypercapnic COPD patients? Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017
Inhibitory effect of SABA on exercise dynamic lung hyperinflation during 6-min walk test in stable COPD patients Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011
The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration Source: Eur Respir J 2003; 21: 82-85 Year: 2003